Research on the motivation and performance of china resources pharmaceutical M&A

Abstract

The pharmaceutical industry plays a crucial role in China's national economy. China's domestic pharmaceutical market is huge and has great development potential. However, at present, the scale and development level of Chinese pharmaceutical enterprises are uneven, and their international competitiveness is weak. In this paper, China Resources Medicine is selected as the research sample, with a specific focus on analyzing continuous mergers and acquisitions initiated by China Resources Medicine during 2016-2021. It is concluded that pharmaceutical enterprises need to allocate resources reasonably and utilize synergistic effect to give full play to their advantages. The identification of risks and deep exploration of potential should be carried out simultaneously, and the blind integration of the industrial chain should be avoided, so as to provide effective reference value for China Resources Pharmaceutical and other related pharmaceutical enterprises in the future development and merger and acquisition activities.